KPC Pharmaceuticals,Inc. (SHA:600422)
13.93
-0.10 (-0.71%)
Oct 9, 2025, 9:45 AM CST
KPC Pharmaceuticals,Inc. Market Cap
KPC Pharmaceuticals,Inc. has a market cap or net worth of 10.57 billion as of October 8, 2025. Its market cap has increased by 1.73% in one year.
Market Cap
10.57B
Enterprise Value
10.75B
Revenue
7.96B
Ranking
n/a
PE Ratio
18.40
Stock Price
13.93
Market Cap Chart
Since March 21, 2006, KPC Pharmaceuticals,Inc.'s market cap has increased from 1.22B to 10.57B, an increase of 764.66%. That is a compound annual growth rate of 11.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 10.57B | -11.92% |
Dec 31, 2024 | 12.00B | -24.12% |
Dec 29, 2023 | 15.81B | 47.68% |
Dec 30, 2022 | 10.71B | 27.78% |
Dec 31, 2021 | 8.38B | 27.75% |
Dec 31, 2020 | 6.56B | -19.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 476.78B |
WuXi AppTec | 328.32B |
Shenzhen Mindray Bio-Medical Electronics | 297.14B |
Sichuan Biokin Pharmaceutical | 154.95B |
Shanghai United Imaging Healthcare | 124.40B |
Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
Aier Eye Hospital Group | 114.71B |
Yunnan Baiyao Group Co.,Ltd | 101.26B |